1. Nicolaides KH. Screening for foetal aneuploidies at 11 to 13 weeks. Prenat Diagn 2011;31:7-15.
2. American College of Obstetricians and Gynecologists Committee on Genetics. Committee opinion no. 545: non-invasive prenatal testing for foetal aneuploidy. Obstet Gynecol 2012;120:1532-4.
3. Malone FD, Canick JA, Ball RH, et al. First-trimester or second-trimester screening, or both, for Down’s syndrome. N Engl J Med 2005;353:2001-11.
En 5 points
VIH : la PrEP injectable en pratique
Cas clinique
Les actinomycoses pelviennes
Recommandations
Surveillance et gestion des effets indésirables des immunothérapies
Infographie
Les durées d’antibiothérapies courantes